110 related articles for article (PubMed ID: 10767363)
1. Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sakita I; Komoike Y; Miyazaki M; Ooka M; Masuda N; Fujiwara Y; Ohnishi T; Tomita N; Sekimoto M; Ohue M; Ikeda T; Kobayashi T; Horii A; Monden M
Oncol Rep; 2000; 7(3):529-33. PubMed ID: 10767363
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
3. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
[TBL] [Abstract][Full Text] [Related]
4. LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast.
Lininger RA; Park WS; Man YG; Pham T; MacGrogan G; Zhuang Z; Tavassoli FA
Hum Pathol; 1998 Oct; 29(10):1113-8. PubMed ID: 9781650
[TBL] [Abstract][Full Text] [Related]
5. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
[TBL] [Abstract][Full Text] [Related]
7. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
8. An allelotype of papillary thyroid cancer.
Califano JA; Johns MM; Westra WH; Lango MN; Eisele D; Saji M; Zeiger MA; Udelsman R; Koch WM; Sidransky D
Int J Cancer; 1996 Dec; 69(6):442-4. PubMed ID: 8980243
[TBL] [Abstract][Full Text] [Related]
9. Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma.
Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
Clin Cancer Res; 2000 May; 6(5):1819-25. PubMed ID: 10815903
[TBL] [Abstract][Full Text] [Related]
10. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas.
Ward LS; Brenta G; Medvedovic M; Fagin JA
J Clin Endocrinol Metab; 1998 Feb; 83(2):525-30. PubMed ID: 9467569
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
12. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.
McCarthy RP; Wang M; Jones TD; Strate RW; Cheng L
Clin Cancer Res; 2006 Apr; 12(8):2414-8. PubMed ID: 16638846
[TBL] [Abstract][Full Text] [Related]
13. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
[TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma.
Komoike Y; Tamaki Y; Sakita I; Tomita N; Ohue M; Sekimoto M; Miyazaki M; Kadota M; Masuda N; Ooka M; Ohnishi T; Nakano Y; Kozaki T; Kobayashi T; Matsuura N; Ikeda T; Horii A; Monden M
Int J Oncol; 1999 Jun; 14(6):1157-62. PubMed ID: 10339673
[TBL] [Abstract][Full Text] [Related]
15. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.
Hunt JL; Tometsko M; LiVolsi VA; Swalsky P; Finkelstein SD; Barnes EL
Am J Surg Pathol; 2003 Dec; 27(12):1559-64. PubMed ID: 14657716
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity in 73 human thyroid tumors.
Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma.
Kubo K; Yoshimoto K; Yokogoshi Y; Tsuyuguchi M; Saito S
Jpn J Cancer Res; 1991 Oct; 82(10):1097-103. PubMed ID: 1683348
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
Rodrigues-Serpa A; Catarino A; Soares J
Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
[TBL] [Abstract][Full Text] [Related]
19. The Tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms.
Filie AC; Chiesa A; Bryant BR; Merino MJ; Sobel ME; Abati A
Cancer; 1999 Aug; 87(4):238-42. PubMed ID: 10455213
[TBL] [Abstract][Full Text] [Related]
20. Infrequent CDKN2 mutation in human differentiated thyroid cancers.
Tung WS; Shevlin DW; Bartsch D; Norton JA; Wells SA; Goodfellow PJ
Mol Carcinog; 1996 Jan; 15(1):5-10. PubMed ID: 8561866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
